Streetbeat News

Earnings

VEEE

Twin Vee PowerCats (NASDAQ:VEEE) reported a 75% increase in quarterly losses to $(0.14) per share from $(0.08) per share YoY. Sales also decreased by 4.64% to $8.13 million from $8.52 million YoY.

Portfolio Pulse from mahesh@benzinga.com

August 14, 2023 | 12:30 pm

ENVB

Enveric Biosciences reported Q2 losses of $(3.04) per share, a 11.36% decrease from the same period last year.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:29 pm

RMTI

Rockwell Medical Inc (RMTI) reported Q2 FY23 revenue of $18.1 million, in line with consensus. The company's gross profit was lower than the previous year, but it beat the analyst consensus for EPS loss. The company has raised its revenue and gross profit outlook for FY23 and expects to achieve profitability from operations in Q4 2023. RMTI shares are up by 5.7% in premarket trading.

Portfolio Pulse from Lekha Gupta

August 14, 2023 | 12:26 pm

VBIV

VBI Vaccines reported Q2 losses of $(2.17) per share, missing the analyst consensus estimate of $(2.16) by 0.46 percent. This is a 19.63 percent increase over losses from the same period last year. The company also reported quarterly sales of $720.00 thousand, missing the analyst consensus estimate of $930.00 thousand by 22.58 percent. This is a 108.09 percent increase over sales from the same period last year.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:26 pm

VBLT

Vascular Biogenics (NASDAQ:VBLT) reported Q2 losses of $(0.01) per share, a 91.67% increase over losses of $(0.12) per share from the same period last year.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:24 pm

OTLK

Outlook Therapeutics (NASDAQ:OTLK) reported Q3 losses of $(0.08) per share, which is unchanged from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 12:24 pm

SEEL

Seelos Therapeutics, Inc. (NASDAQ:SEEL) has provided a clinical update for Q2 2023. The company expects to release top-line data for its studies on SLS-002 for Acute Suicidal Ideation and Behavior in adults with Major Depressive Disorder in Q3 2023, and SLS-005 in ALS in Q4 2023. Seelos has also regained compliance with Nasdaq Listing Rule 5500(a)(2).

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:24 pm

CLNN

Clene (NASDAQ:CLNN) reported Q2 losses of $(0.29) per share, missing the analyst consensus estimate of $(0.12) by 141.67%. This is a 314.29% decrease over losses from the same period last year. However, the company's quarterly sales of $269.00K beat the analyst consensus estimate of $120.00K by 124.17%, marking a 668.57% increase over sales from the same period last year.

Portfolio Pulse from Happy Mohamed

August 14, 2023 | 12:22 pm

ONFO

Onfolio Holdings (NASDAQ:ONFO) reported Q2 losses of $(0.26) per share and sales of $1.31 million.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 12:21 pm

GHSI

Guardion Health Sciences (NASDAQ:GHSI) reported a 14.81% decrease in sales this quarter, with revenues of $2.79 million compared to $3.28 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 14, 2023 | 12:21 pm